Articles

1. De la Fuente-Hernandez MA, Sarabia-Sanchez MA, Melendez-Zajgla J, Maldonado-Lagunas V: Role of lncRNAs into Mesenchymal Stromal Cell Differentiation. Am J Physiol Cell Physiol 2022.

2. De la Fuente-Hernandez MA, Alanis-Manriquez EC, Ferat-Osorio E, Rodriguez-Gonzalez A, Arriaga-Pizano L, Vazquez-Santillan K, Melendez-Zajgla J, Fragoso-Ontiveros V, Alvarez-Gomez RM, Maldonado Lagunas V: Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells. Cell Oncol (Dordr) 2022.

3. Zampedri C, Martinez-Flores WA, Melendez-Zajgla J: The Use of Zebrafish Xenotransplant Assays to Analyze the Role of lncRNAs in Breast Cancer. Front Oncol 2021, 11:687594.

4. Sanchez-Lopez JM, Mandujano-Tinoco EA, Garcia-Venzor A, Lozada-Rodriguez LF, Zampedri C, Uribe-Carvajal S, Melendez-Zajgla J, Maldonado V, Lizarraga F: Integrative analysis of transcriptional profile reveals LINC00052 as a suppressor of breast cancer cell migration. Cancer Biomark 2021, 30(4):365-379.

5. Ordaz-Ramos A, Rosales-Gallegos VH, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K: The Role of LGR4 (GPR48) in Normal and Cancer Processes. Int J Mol Sci 2021, 22(9).

6. Melendez-Zajgla J, Maldonado V: The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2021, 22(12).

7. Garcia-Venzor A, Rueda-Zarazua B, Marquez-Garcia E, Maldonado V, Moncada-Morales A, Olivera H, Lopez I, Zuñiga J, Melendez-Zajgla J: SARS-CoV-2 Direct Detection Without RNA Isolation With Loop-Mediated Isothermal Amplification (LAMP) and CRISPR-Cas12. Front Med (Lausanne) 2021, 8:627679.

8. Espinosa M, Lizárraga F, Vázquez-Santillán K, Hidalgo-Miranda A, Piña-Sánchez P, Torres J, García-Ramírez RA, Maldonado V, Melendez-Zajgla J, Ceballos-Cancino G: Coexpression of Smac/DIABLO and Estrogen Receptor in breast cancer. Cancer Biomark 2021, 30(4):429-446.

9. Egusquiza-Alvarez CA, Castañeda-Patlán MC, Albarran-Gutierrez S, Gonzalez-Aguilar H, Moreno-Londoño AP, Maldonado V, Melendez-Zajgla J, Robles-Flores M: Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells. Front Oncol 2021, 11:642940.

10. Schwarz-Cruz YCA, Ceballos-Cancino G, Vazquez-Santillan K, Espinosa M, Zampedri C, Bahena I, Ruiz V, Maldonado V, Melendez-Zajgla J: Basal-Type Breast Cancer Stem Cells Over-Express Chromosomal Passenger Complex Proteins. Cells 2020, 9(3).

11. Sanchez P, Espinosa M, Maldonado V, Barquera R, Belem-Gabino N, Torres J, Cravioto A, Melendez-Zajgla J: Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern. Mol Biol Rep 2020, 47(7):5175-5184.

12. Mendoza-Almanza G, Burciaga-Hernandez L, Maldonado V, Melendez-Zajgla J, Olmos J: Role of platelets and breast cancer stem cells in metastasis. World J Stem Cells 2020, 12(11):1237-1254.

13. Garcia-Venzor A, Mandujano-Tinoco EA, Ruiz-Silvestre A, Sanchez JM, Lizarraga F, Zampedri C, Melendez-Zajgla J, Maldonado V: lncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells. Carcinogenesis 2020, 41(11):1485-1497.

14. FernAndez-Rojas MA, Melendez-Zajgla J, Lagunas VM: lincRNA-RP11400K9.4 Regulates Cell Survival and Migration of Breast Cancer Cells. Cancer Genomics Proteomics 2020, 17(6):769-779.

15. Dominguez-Rosado I, Melendez-Zajgla J: Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy. Rev Invest Clin 2020, 72(6):333-336.

16. Castro-Oropeza R, Vazquez-Santillan K, Diaz-Gastelum C, Melendez-Zajgla J, Zampedri C, Ferat-Osorio E, Rodriguez-Gonzalez A, Arriaga-Pizano L, Maldonado V: Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer. Sci Rep 2020, 10(1):14205.

17. Ruiz-Zamora RA, Guillaume S, Al-Hilaly YK, Al-Garawi Z, Rodriguez-Alvarez FJ, Zavala-Padilla G, Perez-Carreon JI, Rodriguez-Ambriz SL, Herrera GA, Becerril-Lujan B et al: The CDR1 and Other Regions of Immunoglobulin Light Chains are Hot Spots for Amyloid Aggregation. Sci Rep 2019, 9(1):3123.

18. Orlova Z, Pruefer F, Castro-Oropeza R, Ordaz-Ramos A, Zampedri C, Maldonado V, Vazquez-Santillan K, Melendez-Zajgla J: IKKepsilon regulates the breast cancer stem cell phenotype. Biochim Biophys Acta Mol Cell Res 2019, 1866(4):598-611.

19. Munoz-Galindo L, Melendez-Zajgla J, Pacheco-Fernandez T, Rodriguez-Sosa M, Mandujano-Tinoco EA, Vazquez-Santillan K, Castro-Oropeza R, Lizarraga F, Sanchez-Lopez JM, Maldonado V: Changes in the transcriptome profile of breast cancer cells grown as spheroids. Biochem Biophys Res Commun 2019, 516(4):1258-1264.

20. Garcia-Venzor A, Mandujano-Tinoco EA, Lizarraga F, Zampedri C, Krotzsch E, Salgado RM, Davila-Borja VM, Encarnacion-Guevara S, Melendez-Zajgla J, Maldonado V: Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells. Biochim Biophys Acta Mol Cell Res 2019, 1866(12):118523.

21. Camacho-Moctezuma B, Quevedo-Castillo M, Melendez-Zajgla J, Aquino-Jarquin G, Martinez-Ruiz GU: YY1 negatively regulates the XAF1 gene expression in prostate cancer. Biochem Biophys Res Commun 2019, 508(3):973-979.

22. Munguia-Reyes A, Balderas-Martinez YI, Becerril C, Checa M, Ramirez R, Ortiz B, Melendez-Zajgla J, Pardo A, Selman M: R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior. Am J Respir Cell Mol Biol 2018, 59(1):65-76.

23. Melendez-Zajgla J, Mercado-Celis GE, Gaytan-Cervantes J, Torres A, Gabino NB, Zapata-Tarres M, Juarez-Villegas LE, Lezama P, Maldonado V, Ruiz-Monroy K et al: Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome. Sci Rep 2018, 8(1):3252.

24. Mandujano-Tinoco EA, Garcia-Venzor A, Melendez-Zajgla J, Maldonado V: New emerging roles of microRNAs in breast cancer. Breast Cancer Res Treat 2018, 171(2):247-259.

25. Jimenez-Hernandez LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, Munoz-Galindo L, Gonzalez-Torres C, Cortes-Gonzalez CC, Victoria-Acosta G, Melendez-Zajgla J, Maldonado V: NRP1-positive lung cancer cells possess tumor-initiating properties. Oncol Rep 2018, 39(1):349-357.

26. Cervantes-Garduno A, Zampedri C, Espinosa M, Maldonado V, Melendez-Zajgla J, Ceballos-Cancino G: MT4-MMP Modulates the Expression of miRNAs in Breast Cancer Cells. Arch Med Res 2018, 49(7):471-478.

27. Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K: The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol (Dordr) 2018, 41(6):585-603.

28. Rodríguez-Peredo SM, Castellanos-Jankiewicz AK, Imaz-Rosshandler I, Espinoza-Camacho MA, Rangel-Escareño C, Muñoz-Sánchez JL, Melendez-Zajgla J, Tejero ME, Carbó R, Maldonado V et al: Modulation of the lung RNAome in a metabolic syndrome rat model. Int J Clin Exp Pathol 2017, 10(5):5379-5392.

29. Mandujano-Tinoco EA, Garcia-Venzor A, Munoz-Galindo L, Lizarraga-Sanchez F, Favela-Orozco A, Chavez-Gutierrez E, Krotzsch E, Salgado RM, Melendez-Zajgla J, Maldonado V: miRNA expression profile in multicellular breast cancer spheroids. Biochim Biophys Acta Mol Cell Res 2017, 1864(10):1642-1655.

30. Gaytan-Cervantes J, Gonzalez-Torres C, Maldonado V, Zampedri C, Ceballos-Cancino G, Melendez-Zajgla J: Protein Sam68 regulates the alternative splicing of survivin DEx3. J Biol Chem 2017, 292(33):13745-13757.

31. Garay Sanchez SA, Rodriguez Alvarez FJ, Zavala-Padilla G, Mejia-Cristobal LM, Cruz-Rangel A, Costas M, Fernandez Velasco DA, Melendez-Zajgla J, Del Pozo-Yauner L: Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis. Biol Chem 2017, 398(4):477-489.

32. Vazquez-Santillan K, Melendez-Zajgla J, Jimenez-Hernandez LE, Gaytan-Cervantes J, Munoz-Galindo L, Pina-Sanchez P, Martinez-Ruiz G, Torres J, Garcia-Lopez P, Gonzalez-Torres C et al: NF-kappaBeta-inducing kinase regulates stem cell phenotype in breast cancer. Sci Rep 2016, 6:37340.

33. Schwarz-Cruz YCA, Espinosa M, Maldonado V, Melendez-Zajgla J: Advances in the knowledge of breast cancer stem cells. A review. Histol Histopathol 2016, 31(6):601-612.

34. Pruefer F, Vazquez-Santillan K, Munoz-Galindo L, Cruz-Colin JL, Maldonado V, Melendez-Zajgla J: TIMP4 Modulates ER-alpha Signalling in MCF7 Breast Cancer Cells. Folia Biol (Praha) 2016, 62(2):75-81.

35. Pacheco-Marin R, Melendez-Zajgla J, Castillo-Rojas G, Mandujano-Tinoco E, Garcia-Venzor A, Uribe-Carvajal S, Cabrera-Orefice A, Gonzalez-Torres C, Gaytan-Cervantes J, Mitre-Aguilar IB et al: Transcriptome profile of the early stages of breast cancer tumoral spheroids. Sci Rep 2016, 6:23373.

36. Lopez-Marure R, Zapata-Gomez E, Rocha-Zavaleta L, Aguilar MC, Espinosa Castilla M, Melendez Zajgla J, Meraz-Cruz N, Huesca-Gomez C, Gamboa-Avila R, Gomez-Gonzalez EO: Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines. Cancer Biol Ther 2016, 17(9):915-924.

37. Lizarraga F, Espinosa M, Ceballos-Cancino G, Vazquez-Santillan K, Bahena-Ocampo I, Schwarz-Cruz YCA, Vega-Gordillo M, Garcia Lopez P, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells. Mol Carcinog 2016, 55(12):1952-1961.

38. Campos-Arroyo D, Maldonado V, Bahena I, Quintanar V, Patino N, Carlos Martinez-Lazcano J, Melendez-Zajgla J: Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin. Cancer Invest 2016, 34(3):155-166.

39. Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Garcia-Lopez P, Maldonado V, Melendez-Zajgla J: miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation. EMBO Rep 2016, 17(7):1081.

40. Victoria-Acosta G, Vazquez-Santillan K, Jimenez-Hernandez L, Munoz-Galindo L, Maldonado V, Martinez-Ruiz GU, Melendez-Zajgla J: Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding. Sci Rep 2015, 5:14838.

41. Vazquez-Santillan K, Melendez-Zajgla J, Jimenez-Hernandez L, Martinez-Ruiz G, Maldonado V: NF-kappaB signaling in cancer stem cells: a promising therapeutic target? Cell Oncol (Dordr) 2015, 38(5):327-339.

42. Salcido-Neyoy ME, Sanchez-Perez Y, Osornio-Vargas AR, Gonsebatt ME, Melendez-Zajgla J, Morales-Barcenas R, Petrosyan P, Molina-Servin ED, Vega E, Manzano-Leon N et al: Induction of c-Jun by air particulate matter (PM(1)(0)) of Mexico city: Participation of polycyclic aromatic hydrocarbons. Environ Pollut 2015, 203:175-182.

43. Morales-Barcenas R, Chirino YI, Sanchez-Perez Y, Osornio-Vargas AR, Melendez-Zajgla J, Rosas I, Garcia-Cuellar CM: Particulate matter (PM(1)(0)) induces metalloprotease activity and invasion in airway epithelial cells. Toxicol Lett 2015, 237(3):167-173.

44. Mejia-Cristobal LM, Reus E, Lizarraga F, Espinosa M, Ceballos-Cancino G, Lopez TV, Garay S, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteases-4 (TIMP-4) modulates adipocyte differentiation in vitro. Exp Cell Res 2015, 335(2):207-215.

45. Lizarraga F, Ceballos-Cancino G, Espinosa M, Vazquez-Santillan K, Maldonado V, Melendez-Zajgla J: Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells. PLoS One 2015, 10(8):e0135929.

46. Torres Mena JE, Sanchez Rodriguez R, Quintanar Jurado V, Mojica Espinosa R, Del Pozo Yauner L, Melendez Zajgla J, Villa Trevino S, Perez Carreon JI: Laser capture microdissection after gamma-glutamyl transferase histochemistry: an optimization for gene expression analysis. Anal Biochem 2014, 447:126-132.

47. Sanchez-Rodriguez R, Torres-Mena JE, De-la-Luz-Cruz M, Bernal-Ramos GA, Villa-Trevino S, Chagoya-Hazas V, Landero-Lopez L, Garcia-Roman R, Rouimi P, Del-Pozo-Yauner L et al: Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats. Int J Biochem Cell Biol 2014, 53:186-194.

48. Salazar-Olivo LA, Mejia-Elizondo R, Alonso-Castro AJ, Ponce-Noyola P, Maldonado-Lagunas V, Melendez-Zajgla J, Saavedra-Alanis VM: SerpinA3g participates in the antiadipogenesis and insulin-resistance induced by tumor necrosis factor-alpha in 3T3-F442A cells. Cytokine 2014, 69(2):180-188.

49. Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS et al: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A 2014, 111(51):E5564-5573.

50. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B et al: Landscape of genomic alterations in cervical carcinomas. Nature 2014, 506(7488):371-375.

51. Melendez-Zajgla J, Maldonado Lagunas V: Genomes of the cancer. Where do we go from here? Gaceta Medica De Mexico 2014, 150(6):563-569.

52. Martinez-Ruiz GU, Victoria-Acosta G, Vazquez-Santillan KI, Jimenez-Hernandez L, Munoz-Galindo L, Ceballos-Cancino G, Maldonado V, Melendez-Zajgla J: Ectopic expression of new alternative splice variant of Smac/DIABLO increases mammospheres formation. Int J Clin Exp Pathol 2014, 7(9):5515-5526.

53. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA et al: Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013, 499(7457):214-218.

54. Garcia I, Cosio G, Lizarraga F, Martinez-Ruiz G, Melendez-Zajgla J, Ceballos G, Espinosa M, Pacheco R, Maldonado V: Bcl-3 regulates UVB-induced apoptosis. Hum Cell 2013, 26(2):47-55.

55. Ceballos-Cancino G, Melendez-Zajgla J: DIABLO (diablo, IAP-binding mitochondrial protein). Atlas Genet Cytogenet Oncol Haematol 2013(http://AtlasGeneticsOncology.org/Genes/DIABLOID42995ch12q24.html).

56. Montes E, Ruiz V, Checa M, Maldonado V, Melendez-Zajgla J, Montano M, Ordonez-Razo R, Cisneros J, Garcia-de-Alba C, Pardo A et al: Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis. Eur Respir J 2012, 39(1):141-148.

57. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL et al: Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 2012, 109(10):3879-3884.

58. Espinosa M, Ceballos-Cancino G, Callaghan R, Maldonado V, Patino N, Ruiz V, Melendez-Zajgla J: Survivin isoform Delta Ex3 regulates tumor spheroid formation. Cancer Lett 2012, 318(1):61-67.

59. Campos-Arroyo D, Martinez-Lazcano JC, Melendez-Zajgla J: Probenecid is a chemosensitizer in cancer cell lines. Cancer Chemother Pharmacol 2012, 69(2):495-504.

60. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L et al: Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486(7403):405-409.

61. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A et al: The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333(6046):1157-1160.

62. Schwarz-Cruz-y-Celis A, Melendez-Zajgla J: Cancer stem cells. Rev Invest Clin 2011, 63(2):179-186.

63. Maldonado V, Melendez-Zajgla J: Role of Bcl-3 in solid tumors. Mol Cancer 2011, 10:152.

64. Zamora R, Espinosa M, Ceballos-Cancino G, Segura B, Maldonado V, Melendez-Zajgla J: Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells. Mol Cancer 2010, 9:223.

65. Soberon-Mainero X, Melendez-Zajgla J: [The Instituto Nacional de Medicina Genomica. Vocation and challenges]. Rev Invest Clin 2010, 62(5):391-392.

66. Munoz L, Espinosa M, Quintanar-Jurado V, Hidalgo A, Melendez-Zajgla J, Maldonado V: Paradoxial changes in the expression of estrogen receptor alpha in breast cancer multicellular spheroids. Tissue Cell 2010, 42(5):334-337.

67. Maldonado V, Espinosa M, Pruefer F, Patino N, Ceballos-Canciono G, Urzua U, Juretic N, Melendez-Zajgla J: Gene regulation by BCL3 in a cervical cancer cell line. Folia Biol (Praha) 2010, 56(4):183-193.

68. Perez-Rojas JM, Cruz C, Garcia-Lopez P, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Ceballos G, Espinosa M, Melendez-Zajgla J, Pedraza-Chaverri J: Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 2009, 43(11):1122-1132.

69. Melendez-Zajgla J: Personalized medicine. So close and so far away. Revista De Investigacion Clinica-Clinical and Translational Investigation 2009, 61(6):454-455.

70. Gallardo-Perez JC, Espinosa M, Ceballos-Cancino G, Daniel A, Rodriguez-Enriquez S, Aviles A, Moreno-Sanchez R, Melendez-Zajgla J, Maldonado V: NF-kappa B is required for the development of tumor spheroids. J Cell Biochem 2009, 108(1):169-180.

71. Pruefer FG, Lizarraga F, Maldonado V, Melendez-Zajgla J: Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J Chemother 2008, 20(3):348-354.

72. Meléndez-Zajgla J, G C-C: Sobreviviendo a diablo: lecciones de la survivina en la apoptosis Mensaje Bioquímico 2008, 32:175-184.

73. Melendez-Zajgla J, Del Pozo L, Ceballos G, Maldonado V: Tissue inhibitor of metalloproteinases-4. The road less traveled. Mol Cancer 2008, 7:85.

74. Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J: Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res 2008, 27:48.

75. Lagunas VM, Melendez-Zajgla J: Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs. Met Based Drugs 2008, 2008:576104.

76. Ramirez-Ortega M, Zarco G, Maldonado V, Carrillo JF, Ramos P, Ceballos G, Melendez-Zajgla J, Garcia N, Zazueta C, Chanona J et al: Is digitalis compound-induced cardiotoxicity, mediated through guinea-pig cardiomyocytes apoptosis? Eur J Pharmacol 2007, 566(1-3):34-42.

77. Padilla C, Hernández A, Sobrino S, Alonso O, Sánchez del Monte J, Maldonado V, Meléndez-Zajgla J: TNF alfa como marcador tumoral en cáncer gástrico. Endoscopia 2007, 19(4):241-247.

78. Montesinos M, Hernández A, Sobrino S, Alonso O, Meléndez-Zajgla J, Maldonado V, Tenorio T, Aviles A: Angiogénesis temprana inducida por oxigenación hiperbárica como predictor de respuesta clínica en pacientes con proctopatía por radiación. Endoscopia 2007, 19(4):352-357.

79. Melendez-Zajgla J, Maldonado V: A modified method for cloning adherent mammalian cells. Bioquimia 2007, 32(2):70-72.

80. Melendez-Zajgla J, Maldonado V: Is cancer a transmittable disease? Gaceta Medica De Mexico 2007, 143(4):353-354.

81. Martinez-Velazquez M, Melendez-Zajgla J, Maldonado V: Apoptosis induced by cAMP requires Smac/DIABLO transcriptional upregulation. Cell Signal 2007, 19(6):1212-1220.

82. Ceballos-Cancino G, Espinosa M, Maldonado V, Melendez-Zajgla J: Regulation of mitochondrial Smac/DIABLO-selective release by survivin. Oncogene 2007, 26(54):7569-7575.

83. Ramirez-Ortega M, Maldonado-Lagunas V, Melendez-Zajgla J, Carrillo-Hernandez JF, Pastelin-Hernandez G, Picazo-Picazo O, Ceballos-Reyes G: Proliferation and apoptosis of HeLa cells induced by in vitro stimulation with digitalis. Eur J Pharmacol 2006, 534(1-3):71-76.

84. Pruefer FG, Unger-Saldana K, Mohamier L, Ramirez M, Suarez J, Ramirez MT, Maldonado V, Melendez-Zajgla J: Tumor HGF lacks prognostic significance in Mexican breast cancer patients. J Exp Clin Cancer Res 2006, 25(3):357-364.

85. Mendoza J, Zamora R, Gallardo JC, Ceballos G, Aldana A, Espinosa M, Maldonado V, Melendez-Zajgla J: NF-kappaB does not influence the induction of apoptosis by Ukrain. Cancer Biol Ther 2006, 5(7):788-793.

86. Martinez-Velazquez M, Maldonado V, Ortega A, Melendez-Zajgla J, Albores A: Benzene metabolites induce apoptosis in lymphocytes. Exp Toxicol Pathol 2006, 58(1):65-70.

87. Gallardo Pérez J, Espinosa Castilla M, Meléndez Zajgla J, Maldonado V: Esferoides tumorales multicelulares en la evaluación de estrategias terapéuticas anticancerosas. Revista de Educación Bioquímica 2006, 25(4):101-107.

88. Espinosa M, Cantu D, Herrera N, Lopez CM, De la Garza JG, Maldonado V, Melendez-Zajgla J: Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer 2006, 6:45.

89. Ayala G, Torres L, Espinosa M, Fierros-Zarate G, Maldonado V, Melendez-Zajgla J: External membrane vesicles from Helicobacter pylori induce apoptosis in gastric epithelial cells. FEMS Microbiol Lett 2006, 260(2):178-185.

90. Arellano-Llamas A, Garcia FJ, Perez D, Cantu D, Espinosa M, De la Garza JG, Maldonado V, Melendez-Zajgla J: High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. BMC Cancer 2006, 6:256.

91. Lizarraga F, Espinosa M, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteinases-4 is expressed in cervical cancer patients. Anticancer Res 2005, 25(1b):623-627.

92. Espinosa M, Martinez M, Aguilar JL, Mota A, De la Garza JG, Maldonado V, Melendez-Zajgla J: Oxaliplatin activity in head and neck cancer cell lines. Cancer Chemother Pharmacol 2005, 55(3):301-305.

93. Martinez M, Moran J, Maldonado V, Melendez-Zajgla J: Smac/DIABLO y su papel en apoptosis. . Revista de Educación Bioquímica 2004, 23(2):64-70.

94. Lizarraga F, Maldonado V, Melendez-Zajgla J: Tissue inhibitor of metalloproteinases-2 growth-stimulatory activity is mediated by nuclear factor-kappa B in A549 lung epithelial cells. Int J Biochem Cell Biol 2004, 36(8):1655-1663.

95. Espinosa M, Cantu D, Lopez CM, De la Garza JG, Maldonado VA, Melendez-Zajgla J: SMAC is expressed de novo in a subset of cervical cancer tumors. BMC Cancer 2004, 4:84.

96. Montero O, Salle MT, Guevara R, Olivera P, Maldonado V, Melendez-Zajgla J: Cytogenetic analysis of the mononuclear cell component of giant cell tumors of bone. Cancer Genet Cytogenet 2003, 146(2):170-172.

97. Elinos-Baez CM, Maldonado V, Melendez-Zajgla J: [Caspases: apoptosis inducing molecules]. Gac Med Mex 2003, 139(5):493-499.

98. Ramirez Ortega Mdel C, Maldonado Lagunas V, Melendez Zajgla J, Zarco Olvera G, Avila Casados Mdel C, Suarez Munguia J, Pastelin Hernandez G: [Mechanism of cellular toxicity induced by digitalis compounds. Study with ouabain]. Arch Cardiol Mex 2002, 72 Suppl 1:S171-176.

99. Olivera P, Perez E, Ortega A, Terual R, Gomes C, Moreno LF, Duenas A, De La Garza J, Melendez-Zajgla J, Maldonado V: Estrogen receptor expression in giant cell tumors of the bone. Hum Pathol 2002, 33(2):165-169.

100. Lopez L, Villavicencio MA, Albores A, Martinez M, de la Garza J, Melendez-Zajgla J, Maldonado V: Cupressus lusitanica (Cupressaceae) leaf extract induces apoptosis in cancer cells. J Ethnopharmacol 2002, 80(2-3):115-120.

101. Hernandez P, Olivera P, Duenas-Gonzalez A, Perez-Pastenes MA, Zarate A, Maldonado V, Melendez-Zajgla J: Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 2001, 48(6):488-492.

102. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez A, Reyes M, Mota A, Munoz D, Solorza G, Hinojosa LM, Guadarrama R, Florentino R et al: A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 2001, 12(4):541-547.

103. Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J: Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 2001, 62(1):13-19.

104. Vazquez de Lara L, Becerril C, Montano M, Ramos C, Maldonado V, Melendez J, Phelps DS, Pardo A, Selman M: Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol Lung Cell Mol Physiol 2000, 279(5):L950-957.

105. Melendez J, Maldonado V, Bingle CD, Selman M, Pardo A: Cloning and expression of guinea pig TIMP-2. Expression in normal and hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 2000, 278(4):L737-743.

106. De Lara LV, Becerril C, Montano M, Ramos C, Maldonado V, Melendez J, Phelps DS, Pardo A, Selman M: Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. American Journal of Physiology-Lung Cellular and Molecular Physiology 2000, 279(5):L950-L957.

107. Melendez-Zajgla J, Cruz E, Maldonado V, Espinoza AM: Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin. Biochem Mol Biol Int 1999, 47(5):765-771.

108. Velazquez M, Maldonado V, Melendez-Zajgla J: Cisplatin-induced apoptosis of HeLa cells. Effect of RNA and protein synthesis inhibitors, Ca2+ chelators and zinc. J Exp Clin Cancer Res 1998, 17(3):277-284.

109. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, Segura-Valdez L, Sznajder JI, Selman M: Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 1998, 153(3):833-844.

110. Melendez Zajgla J, Maldonado Lagunas V: Cisplatino. Avances recientes en su mecanismo de acción. Revista del Instituto Nacional de Cancerologia 1998, 44(1):28-34.

111. Melendez-Zajgla J, Garcia C, Maldonado V: Subcellular redistribution of HSP72 protein during cisplatin-induced apoptosis in HeLa cells. Biochem Mol Biol Int 1996, 40(2):253-261.

112. Melendez J, Maldonado V, Ortega A: Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. Neurochem Res 1996, 21(6):653-658.

113. Maldonado V, De Anda J, Melendez-Zajgla J: Paclitaxel-induced apoptosis in HeLa cells is serum dependent. J Biochem Toxicol 1996, 11(4):183-188.

114. Maldonado V, Melendez J, Gonzalez H, Ortega A: Internucleosomal DNA cleavage in HeLa cells exposed to cisplatin. Biochem Mol Biol Int 1995, 37(4):691-696.

115. Maldonado V, Chan L, Melendez J, Rincon AR, Zhu HJ, Panduro A: Regulation of apo B mRNA expression in liver and intestine during liver regeneration induced by CCl4. Biochim Biophys Acta 1994, 1211(1):1-6.

116. Panduro A, Morales L, Santos A, Valdes L, Lima G, Melendez J, Cabrera G, Maldonado V, Villalobos JJ: [New strategies in the clinical evaluation of patients with colon cancer based on molecular studies]. Rev Gastroenterol Mex 1993, 58(2):119-127.

117. Panduro A, Lima G, Meléndez J, Cabrera G, Del Bosque L, Morales L, Santos J, Villalobos J: Estudios moleculares del cáncerde colon en el Instituto Nacional de la Nutrición Salvador Zubirán. Revista de la Facultad de Medicina 1993, 36:1.

More papers

1. Padilla C, Hernández A, Sobrino S, Alonso O, Sánchez del Monte J, Maldonado V, Meléndez-Zajgla J: TNF alfa como marcador tumoral en cáncer gástrico. Endoscopia 2007, 19(4):241-247.
2. Ceballos-Cancino G, Melendez-Zajgla J: DIABLO (diablo, IAP-binding mitochondrial protein). . Atlas Genet Cytogenet Oncol Haematol 2013(http://AtlasGeneticsOncology.org/Genes/DIABLOID42995ch12q24.html).
3. Gallardo Pérez J, Espinosa Castilla M, Meléndez Zajgla J, Maldonado V: Esferoides tumorales multicelulares en la evalua-ción de estrategias terapéuticas anticancerosas. . Revista de Educación Bioquímica 2006, 25(4):101-107.
4. Montesinos M, Hernández A, Sobrino S, Alonso O, Meléndez-Zajgla J, Maldonado V, Tenorio T, Aviles A: Angiogénesis temprana inducida por oxigenación hiperbárica como predictor de respuesta clínica en pacientes con proctopatía por radiación. Endoscopia 2007, 19(4):352-357.
5. Martinez M, Moran J, Maldonado V, Melendez-Zajgla J: Smac/DIABLO y su papel en apoptosis. . Revista de Educación Bioquímica 2004, 23(2):64-70.
6. Meléndez-Zajgla J, G C-C: Sobreviviendo a diablo: lecciones de la survivina en la apoptosis Mensaje Bioquímico 2008, 32:175-184.
7. Melendez-Zajgla J, Maldonado V: A modified method for cloning adherent mammalian cells. . Bioquimia 2007, 32(2):70-72.
8. Panduro A, Morales L, Santos A, Valdes L, Lima G, Melendez J, Cabrera G, Maldonado V, Villalobos JJ: New strategies in the clinical evaluation of patients with colon cancer based on molecular studies. Revista de gastroenterologia de Mexico 1993, 58(2):119-127.
9. Ramirez Ortega MdC, Maldonado Lagunas V, Melendez Zajgla J, Zarco Olvera G, Avila Casados MDC, Suarez Munguia J, Pastelin Hernandez G: Mechanism of cellular toxicity induced by digitalis compounds. Study with ouabain. Archivos de cardiologia de Mexico 2002, 72 Suppl 1:S171-176.
10. Melendez Zajgla J, Maldonado Lagunas V: Cisplatino. Avances recientes en su mecanismo de acción. Revista del Instituto Nacional de Cancerologia 1998, 44(1):28-34.
11. Panduro A, Lima G, Meléndez J, Cabrera G, Del Bosque L, Morales L, Santos J, Villalobos J: Estudios moleculares del cáncerde colon en el Instituto Nacional de la Nutrición Salvador Zubirán. Revista de la Facultad de Medicina 1993, 36:1.

Science Divulgation

2008. Células troncales: ¿Clave para curar el Cáncer?. Jorge Meléndez Zajgla y Vilma Maldonado Lagunas. Ciencia y Desarrollo. Octubre del 2008.
2009. El lado amable de DIABLO. Jorge Meléndez Zajgla. Gaceta Biomédicas. Noviembre del 2007.
2010. El Instituto Nacional de Medicina Genómica. Vocación y Retos. Soberón-Mainero X, Meléndez-Zajgla, J. Revista de Investigación Clínica. 2010: 62, 391-392